Cargando…
OR12-07 Full Antagonism of Breast Cancer Cell Proliferation Can Result from Many Ligand-Induced Conformational Distortions of the Estrogen Receptor Ligand Binding Domain
Although most estrogen receptor alpha (ERα)-positive breast cancers initially respond well to endocrine therapies using aromatase inhibitors (AIs) or antiestrogens, after varying time periods the cancer frequently recurs as metastatic disease. A significant fraction of these recurrences are driven b...
Autores principales: | Nwachukwu, Jerome, Min, Jian, Srinivasan, Sathish K, Rangarajan, Erumbi, Guillen, Valeria Sanabria, Ziegler, Yvonne, Carlson, Kathryn, Hou, Yingwei, Kim, Sung Hoon, Izard, Tina, Houtman, Rene, Katzenellenbogen, Benita S, Nettles, Kendall W, Katzenellenbogen, John A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209757/ http://dx.doi.org/10.1210/jendso/bvaa046.249 |
Ejemplares similares
-
OR11-01 A New Model for Estrogen Receptor-alpha Antagonist Mechanism of Action
por: Nwachukwu, Jerome C, et al.
Publicado: (2023) -
OR09-2 Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets
por: Zuo, Qianying, et al.
Publicado: (2019) -
OR07-4 Regulation of Mineralocorticoid Receptor Transactivation By Circadian Protein Timeless
por: Young, Morag
Publicado: (2022) -
OR26-2 mTOR Interacts with the Mineralocorticoid Receptor to Regulate its Activation by Ligand
por: Gomez-Sanchez, Celso E, et al.
Publicado: (2022) -
OR07-5 PARP1 Contributes to the Glucocorticoid Receptor Transcriptional Response And Influences the Skeletal Muscle Phenotype
por: Boocock, David, et al.
Publicado: (2022)